<DOC>
	<DOCNO>NCT01066000</DOCNO>
	<brief_summary>This open-label single-arm study evaluate efficacy , safety tolerability methoxy polyethylene glycol epoetin beta long-term maintenance haemoglobin level patient chronic renal anaemia . Patients receive methoxy polyethylene glycol-epoetin beta intravenously monthly initial dos either 120 microgram 200 microgram 360 microgram titration phase 16 week potential dose adjustment evaluation phase 8 week . The anticipated time study treatment 24 week . The target sample size 50-100 patient .</brief_summary>
	<brief_title>A Study Monthly Methoxy Polyethylene Glycol-Epoetin Beta Treatment Patients With Chronic Renal Anaemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>Adults &gt; /=18 year age Chronic renal anaemia Haemoglobin concentration 10 12 g/dL screen Adequate iron status Continuous intravenous maintenance shortacting therapy dose interval 8 week prior screen Regular longterm haemodialysis therapy least 12 week prior screen Change haemoglobin concentration &gt; /=2 g/dL screen Transfusion red blood cell less 8 week prior screen Poorly control hypertension Relevant acute chronic bleed require treatment le 8 week prior screen Active malignant disease Haemolysis Haemoglobinopathies</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>